China NMPA Inspection - Shanghai AnDing Biotechnology (Tangyin) Pharmaceutical Co., Ltd. - December 05, 2018
China NMPA unannounced inspection for Shanghai AnDing Biotechnology (Tangyin) Pharmaceutical Co., Ltd. published December 05, 2018. An unannounced inspection of Shanghai Anding Biotechnology (Tangyin) Pharmaceutical Co., Ltd., conducted by the State Food and Drug Administration wit
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Shanghai AnDing Biotechnology (Tangyin) Pharmaceutical Co., Ltd. published December 05, 2018. An unannounced inspection of Shanghai Anding Biotechnology (Tangyin) Pharmaceutical Co., Ltd., conducted by the State Food and Drug Administration wit
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: 84babcf2-49ed-41f2-aedc-e701506f6cf9
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox